4/16
Coronavirus Research
Researchers begin forming guidance on properly managing COVID-19 patient airways
As the pandemic continues and knowledge about it evolves, a team of researchers has worked to form a consensus on topics including intubation, high-flow nasal oxygen, and the use of personal protective equipment.
COVID-19 patients survive in-hospital cardiac arrest at pre-pandemic rates
Resuscitation and survival rates are much higher than earlier reports of near-zero, and variation at the individual hospital level may have affected overall numbers.
Charting a path forward with unifying definition of cytokine storm
Penn Medicine researchers have developed a unifying definition of “cytokine storm” to provide a framework to assess and treat patients whose immune systems have gone rogue.
Translating groundbreaking scientific discoveries into practical technologies
Amidst the numerous challenges posed by COVID-19, the Penn Center for Innovation has continued to facilitate impactful innovations created at Penn, fostering partnerships and helping to realize new products and businesses.
Uniting against an invisible foe
All across the University, researchers have launched new areas of study, reaching across disciplinary boundaries to make stunning progress in combating COVID-19.
Five things to know about the promising COVID-19 vaccine news
Drew Weissman of the Perelman School of Medicine, whose work is a key factor helping to enable two vaccines in late stages of testing, sheds light on the biology behind them and on his predictions about next steps in vaccine development and approval.
Penn Vice Provost Ezekiel Emanuel named to President-elect Biden’s Transition COVID-19 Advisory Board
Emanuel has been tapped as member of a team of leading public health and scientific experts to advise on the Biden-Harris COVID-19 response.
An ecosystem of innovation fosters tech-based solutions to COVID-19 challenges
Clinicians, engineers, and IT specialists work together at Penn on innovations that help doctors provide the best care for patients amid continued social distancing and coronavirus restrictions.
England, Wales, Scotland among nations with highest death toll from COVID-19 pandemic
An international team including Penn demographer Michel Guillot found that from mid-February through May, 21 industrialized nations combined saw an 18% increase in deaths, or 206,000 more people dying from all causes than would have been expected had the pandemic not occurred.
The unpredictable course of COVID-19
Austin Kilaru, an LDI associate fellow and emergency physician, studied COVID-19 patients who return to the hospital after an initial evaluation in the emergency department, to understand how often people need hospitalization after initially appearing well.
In the News
The mRNA miracle workers
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
Review of COVID death stats finds likely undercount in official numbers
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
The Franklin Institute honors nine scientists and engineers on its 200th anniversary
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
You should still get the COVID-19 vaccine. The Nobel Prize winner who helped discover it explains why
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
Long COVID brain fog may originate in a surprising place, say scientists
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
Long COVID research is in its ‘most hopeful’ phase yet
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →